Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Modzelewski

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 20, 2014
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinomaCharles Lemarignier, Frédéric Di Fiore, Charline Marre, et al.
Frontiers in Medicine|March 15, 2021
Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission TomographyPierre Pinochet, Florian Eude, Stéphanie Becker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 27, 2022
Evaluation of sarcopenia biomarkers in older patients undergoing major surgery for digestive cancer. SAXO prospective cohort studyGuillaume Gagnat, Christian Hobeika, Romain Modzelewski, et al.
Thyroid : Official Journal of the American Thyroid Association|December 19, 2009
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?Pierre Vera, Caroline Kuhn-Lansoy, Agathe Edet-Sanson, et al.
Nuclear Medicine and Biology|September 28, 2015
Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal windowStéphanie Becker, Pierre Bohn, Anne-Charlotte Bouyeure-Petit, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 15, 2015
High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancerJérémie Calais, Bernard Dubray, Lamyaa Nkhali, et al.
Plos One|March 11, 2017
Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifierPaul Desbordes, Su Ruan, Romain Modzelewski, et al.
EJNMMI Physics|March 20, 2025
Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-conceptArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
Head & Neck|March 7, 2017
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinomaAnne Chaput, Jérémie Calais, Philippe Robin, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Nuclear Medicine and Molecular Imaging|July 20, 2014
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinomaCharles Lemarignier, Frédéric Di Fiore, Charline Marre, et al.
Frontiers in Medicine|March 15, 2021
Evaluation of an Automatic Classification Algorithm Using Convolutional Neural Networks in Oncological Positron Emission TomographyPierre Pinochet, Florian Eude, Stéphanie Becker, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|September 27, 2022
Evaluation of sarcopenia biomarkers in older patients undergoing major surgery for digestive cancer. SAXO prospective cohort studyGuillaume Gagnat, Christian Hobeika, Romain Modzelewski, et al.
Thyroid : Official Journal of the American Thyroid Association|December 19, 2009
Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?Pierre Vera, Caroline Kuhn-Lansoy, Agathe Edet-Sanson, et al.
Nuclear Medicine and Biology|September 28, 2015
Bevacizumab enhances efficiency of radiotherapy in a lung adenocarcinoma rodent model: Role of αvβ3 imaging in determining optimal windowStéphanie Becker, Pierre Bohn, Anne-Charlotte Bouyeure-Petit, et al.
Nuclear Medicine Communications|May 9, 2013
Biodistribution and imaging of [99mTc]-HYNIC-RGD in MDA-MB-231 and NTERA-2 cancer cell xenograftsPierre Bohn, Romain Modzelewski, Jean Rouvet, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 15, 2015
High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancerJérémie Calais, Bernard Dubray, Lamyaa Nkhali, et al.
Plos One|March 11, 2017
Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifierPaul Desbordes, Su Ruan, Romain Modzelewski, et al.
EJNMMI Physics|March 20, 2025
Towards fully automatized [177Lu]Lu-PSMA personalized dosimetry based on 360° CZT whole-body SPECT/CT: a proof-of-conceptArnaud Dieudonné, Aya Terro, Arthur Dumouchel, et al.
Head & Neck|March 7, 2017
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinomaAnne Chaput, Jérémie Calais, Philippe Robin, et al.
Pageof 6